Holen Sie sich die Stockscreener-App
28.50
2.90%
-0.85
Handel nachbörslich:
26.00
-2.50
-8.77%
Finanzdaten der Rapt Therapeutics Inc-Aktie (RAPT)
Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
| Enddatum des Zeitraums | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 |
| Periodenlänge | 3 Monate | 3 Monate | 3 Monate | 3 Monate | 3 Monate |
| Revenues |
-
|
- | - | - | - |
Operating Expenses
|
1.40%
19.54
|
19.27 | 54.47 | 19.79 | 29.33 |
| Depreciation and Amortization |
20.63%
0.20
|
0.252 | 0.287 | 0.30 | 0.30 |
| Operating Income/Loss |
1.40%
-19.54
|
-19.27 | -54.47 | -19.79 | -29.33 |
| Nonoperating Income/Loss |
9.90%
1.892
|
2.10 | 1.216 | 1.356 | 1.667 |
| Income/Loss From Continuing Operations Before Tax |
2.78%
-17.64
|
-17.16 | -53.25 | -18.43 | -27.66 |
| Income/Loss From Continuing Operations After Tax |
2.78%
-17.64
|
-17.16 | -53.25 | -18.43 | -27.66 |
|
Net Income/Loss
|
2.78%
-17.64
|
-17.16 | -53.25 | -18.43 | -27.66 |
| Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
| Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
| Basic Average Shares |
87.49%
26.95
|
215.41 | 1.9606 | 38.90 | 38.87 |
| Diluted Average Shares |
87.49%
26.95
|
215.41 | 1.9606 | 38.90 | 38.87 |
| Basic Earnings Per Share |
712.50%
-0.65
|
-0.08 | -1.22 | -0.47 | -0.71 |
| Diluted Earnings Per Share |
712.50%
-0.65
|
-0.08 | -1.22 | -0.47 | -0.71 |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
1.45%
0.86%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):